Patent · US Active

Humanized transgenic animal

US11439132B2 · kind B2 · utility

0Cited by

3References

14Claims

0Family size

Assignee

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. · CN

Inventors

Yuelei Shen · Beijing, CN
Chaoshe Guo · Beijing, CN
Yanan Guo · Beijing, CN
Yang Bai · Beijing, CN
Rui Huang · Beijing, CN
Lei Zhao · Addison, US
Xiaofei Zhou · Beijing, CN
Meiling Zhang · Beijing, CN
Jiawei Yao · Beijing, CN

Key dates

Filing date	Nov 4, 2020
Grant date	Sep 13, 2022
Priority date	—
Expiry date	Nov 4, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA01K2267/0325
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are a humanized transgenic non-human animal, especially a rodent, in particular a transgenic mouse containing a human interleukin 17A (IL-17A) gene, a human gene 17RA (IL-17RA) and/or a human TNF-alpha gene, and a preparation method therefor and the use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.